ACER - Acer Therapeutics Inc
IEX Last Trade
0.769
-0.006 -0.780%
Share volume: 154,841
Last Updated: Tue 08 Aug 2023 09:46:37 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.78
-0.01
-0.77%
Summary score
29%
Profitability
25%
Dept financing
4%
Liquidity
41%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-32.27%
Return on assets
-23.86%
Return on sales
0%
Return on invested capital
-57.34%
Total debt ratio
16.58%
Debt ratio change over timeo
-1.03%
Current Ratio
6.16%
Quick Ratio
0%
Cash Position Ratio
5.88%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-34.4%
Return on assets
-28.15%
Return on sales
0%
Return on invested capital
-89.1%
Total debt ratio
15.44%
Debt ratio change over timeo
-1.17%
Current Ratio
4.53%
Quick Ratio
0%
Cash Position Ratio
4.23%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-51.44%
Return on assets
-36.61%
Return on sales
0%
Return on invested capital
-107.11%
Total debt ratio
24.16%
Debt ratio change over time
-1.33%
Current Ratio
2.09%
Quick Ratio
0%
Cash Position Ratio
1.93%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-90.35%
Return on assets
-89.26%
Return on sales
0%
Return on invested capital
27.6%
Total debt ratio
-103.05%
Debt ratio change over time
-1.03%
Current Ratio
-5.23%
Quick Ratio
0%
Cash Position Ratio
-5.06%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACER | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -32.27% | 0% | 0% | 29.06% |
| Return on assets | -23.86% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | -57.34% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 25% | 50% |
| Total debt ratio | 16.58% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.03% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 4.53% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.23% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 58% |
| Short-term ratios | ACER | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -34.4% | 0% | 0% | -16.12% |
| Return on assets | -28.15% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | -89.1% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 15.44% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.17% | 0% | 0% | 0.09% |
| Dept financing | 5% | 0% | 0% | 50% |
| Current Ratio | 4.53% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.23% | 0% | 0% | 5.68% |
| Liquididy | 38% | 0% | 0% | 75% |